Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s46, 2022. DOI: 10.25251/skin.6.supp.46. Disponível em: https://skin.dermsquared.com/skin/article/view/1801. Acesso em: 23 apr. 2025.